Qinghong Li

1PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 25, 2024
TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma.

Qinghong Li, Kunming Zhang, Yao Yu

Pageof 1

Frequent Collaborators

1 joint publications

Hongyuan Liang